{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:50:32Z","timestamp":1779886232349,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major science and Technology project of Xinjiang Uygur Autonomous Region: Research on key technologies for prevention and treatment of hypertensive kidney damage mediated by aldosterone","award":["No. 2022A03012,  No. 2022A03012-3"],"award-info":[{"award-number":["No. 2022A03012,  No. 2022A03012-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04756-z","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T09:29:44Z","timestamp":1757928584000},"page":"1053-1068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knowledge domains and emerging trends in aldosterone and kidney disease prognosis: a bibliometric analysis"],"prefix":"10.1007","volume":"58","author":[{"given":"Wen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"4756_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.24272\/j.issn.2095-8137.2017.055","volume":"39","author":"YW Bao","year":"2018","unstructured":"Bao YW, Yuan Y, Chen JH, Lin WQ (2018) Kidney disease models: tools to identify mechanisms and potential therapeutic targets. Zool Res 39:72\u201386. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2017.055","journal-title":"Zool Res"},{"key":"4756_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.nefro.2020.03.005","volume":"40","author":"D Martin-Sanchez","year":"2020","unstructured":"Martin-Sanchez D, Fontecha-Barriuso M, Martinez-Moreno JM, Ramos AM, Sanchez-Ni\u00f1o MD, Guerrero-Hue M, Moreno JA, Ortiz A, Sanz AB (2020) Ferroptosis and kidney disease. Nefrologia 40:384\u2013394. https:\/\/doi.org\/10.1016\/j.nefro.2020.03.005","journal-title":"Nefrologia"},{"key":"4756_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/s0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet 392:2052\u20132090. https:\/\/doi.org\/10.1016\/s0140-6736(18)31694-5","journal-title":"Lancet"},{"key":"4756_CR4","doi-asserted-by":"publisher","first-page":"ii159","DOI":"10.1093\/ndt\/gfw270","volume":"32","author":"HC Ainsworth","year":"2017","unstructured":"Ainsworth HC, Langefeld CD, Freedman BI (2017) Genetic epidemiology in kidney disease. Nephrol Dial Transplant 32:ii159\u2013ii169. https:\/\/doi.org\/10.1093\/ndt\/gfw270","journal-title":"Nephrol Dial Transplant"},{"key":"4756_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065370","author":"H Otsuka","year":"2023","unstructured":"Otsuka H, Abe M, Kobayashi H (2023) The effect of aldosterone on cardiorenal and metabolic systems. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065370","journal-title":"Int J Mol Sci"},{"key":"4756_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.kisu.2021.11.006","volume":"12","author":"JM Luther","year":"2011","unstructured":"Luther JM (2011) AB fogo (2022) the role of mineralocorticoid receptor activation in kidney inflammation and fibrosis. Kidney Int Suppl 12:63\u201368. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.006","journal-title":"Kidney Int Suppl"},{"key":"4756_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158099","author":"Y Takeda","year":"2024","unstructured":"Takeda Y, Demura M, Yoneda T, Takeda Y (2024) Epigenetic regulation of the renin-angiotensin-aldosterone system in hypertension. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25158099","journal-title":"Int J Mol Sci"},{"key":"4756_CR8","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.62347\/nrgg6465","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xie B, Pang S, Xie Y, Jili M, Mo Z, Li W, Yang R (2024) Aldosterone\u2019s impact on kidney health: exploring the benefits of mineralocorticoid receptor antagonists for renal protection. Am J Transl Res 16:4246\u20134255. https:\/\/doi.org\/10.62347\/nrgg6465","journal-title":"Am J Transl Res"},{"key":"4756_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2021.10.149","volume":"345","author":"J Biegus","year":"2021","unstructured":"Biegus J, Nawrocka-Millward S, Zymli\u0144ski R et al (2021) Distinct renin\/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure. Int J Cardiol 345:54\u201360. https:\/\/doi.org\/10.1016\/j.ijcard.2021.10.149","journal-title":"Int J Cardiol"},{"key":"4756_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V (2021) Chronic kidney disease. Lancet 398:786\u2013802. https:\/\/doi.org\/10.1016\/s0140-6736(21)00519-5","journal-title":"Lancet"},{"key":"4756_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2302963","volume":"46","author":"J Mao","year":"2024","unstructured":"Mao J, Li C, Wu F, Wang Y, Zhu J, Wen C (2024) The relationship between kidney disease and mitochondria: a bibliometric study. Ren Fail 46:2302963. https:\/\/doi.org\/10.1080\/0886022x.2024.2302963","journal-title":"Ren Fail"},{"key":"4756_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/s0140-6736(23)02408-x","volume":"403","author":"KR Tuttle","year":"2024","unstructured":"Tuttle KR, Hauske SJ, Canziani ME et al (2024) Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. Lancet 403:379\u2013390. https:\/\/doi.org\/10.1016\/s0140-6736(23)02408-x","journal-title":"Lancet"},{"key":"4756_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/ijcp.12803","volume":"70","author":"OJ Ziff","year":"2016","unstructured":"Ziff OJ, Covic A, Goldsmith D (2016) Calibrating the impact of dual RAAS blockade on the heart and the kidney - balancing risks and benefits. Int J Clin Pract 70:537\u2013553. https:\/\/doi.org\/10.1111\/ijcp.12803","journal-title":"Int J Clin Pract"},{"key":"4756_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11906-010-0141-3","volume":"12","author":"G Leoncini","year":"2010","unstructured":"Leoncini G, Viazzi F, Pontremoli R (2010) Chronic kidney disease and albuminuria in arterial hypertension. Curr Hypertens Rep 12:335\u2013341. https:\/\/doi.org\/10.1007\/s11906-010-0141-3","journal-title":"Curr Hypertens Rep"},{"key":"4756_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.kint.2017.08.038","volume":"93","author":"PI Georgianos","year":"2018","unstructured":"Georgianos PI, Agarwal R (2018) Revisiting RAAS blockade in CKD with newer potassium-binding drugs. Kidney Int 93:325\u2013334. https:\/\/doi.org\/10.1016\/j.kint.2017.08.038","journal-title":"Kidney Int"},{"key":"4756_CR16","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00210-023-02575-6","volume":"396","author":"Y Meng","year":"2023","unstructured":"Meng Y, Wang Y, Fu W, Zhang M, Huang J, Wu H, Sun L (2023) Global trends and focuses of GLP-1RA in renal disease: a bibliometric analysis and visualization from 2005 to 2022. Naunyn Schmiedebergs Arch Pharmacol 396:3347\u20133361. https:\/\/doi.org\/10.1007\/s00210-023-02575-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4756_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.767591","volume":"10","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Jin D, Duan Y, Zhang Y, Duan L, Lian F, Tong X (2022) Bibliometric analysis of renal fibrosis in diabetic kidney disease from 1985 to 2020. Front Public Health 10:767591. https:\/\/doi.org\/10.3389\/fpubh.2022.767591","journal-title":"Front Public Health"},{"key":"4756_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10489-017-1105-y","volume":"48","author":"M Guti\u00e9rrez-Salcedo","year":"2018","unstructured":"Guti\u00e9rrez-Salcedo M, Mart\u00ednez M\u00c1, Moral-Munoz JA, Herrera-Viedma E, Cobo MJ (2018) Some bibliometric procedures for analyzing and evaluating research fields. Appl Intell 48:1275\u20131287. https:\/\/doi.org\/10.1007\/s10489-017-1105-y","journal-title":"Appl Intell"},{"key":"4756_CR19","doi-asserted-by":"publisher","first-page":"1112229","DOI":"10.3389\/fcimb.2023.1112229","volume":"13","author":"S He","year":"2023","unstructured":"He S, Wei J, Feng J, Liu D, Wang N, Chen L, Xiong Y (2023) The application of metagenomic next-generation sequencing in pathogen diagnosis: a bibliometric analysis based on web of science. Front Cell Infect Microbiol 13:1112229. https:\/\/doi.org\/10.3389\/fcimb.2023.1112229","journal-title":"Front Cell Infect Microbiol"},{"key":"4756_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31749","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen T, Li C, Qi M, Fu P, Zeng X (2024) Research on coronavirus disease 2019 and the kidney: a bibliometric analysis. Heliyon 10:e31749. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31749","journal-title":"Heliyon"},{"key":"4756_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","volume":"133","author":"N Donthu","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285\u2013296. https:\/\/doi.org\/10.1016\/j.jbusres.2021.04.070","journal-title":"J Bus Res"},{"key":"4756_CR22","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","volume":"102","author":"JE Hirsch","year":"2005","unstructured":"Hirsch JE (2005) An index to quantify an individual\u2019s scientific research output. Proc Natl Acad Sci U S A 102:16569\u201316572. https:\/\/doi.org\/10.1073\/pnas.0507655102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4756_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt KU, Coresh J, Devuyst O, Johnson RJ, K\u00f6ttgen A, Levey AS, Levin A (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382:158\u2013169. https:\/\/doi.org\/10.1016\/s0140-6736(13)60439-0","journal-title":"Lancet"},{"key":"4756_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","volume":"43","author":"R Agarwal","year":"2022","unstructured":"Agarwal R, Filippatos G, Pitt B et al (2022) Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J 43:474\u2013484. https:\/\/doi.org\/10.1093\/eurheartj\/ehab777","journal-title":"Eur Heart J"},{"key":"4756_CR25","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD et al (2020) Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383:2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"key":"4756_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","volume":"66","author":"NK Hollenberg","year":"2004","unstructured":"Hollenberg NK (2004) Aldosterone in the development and progression of renal injury. Kidney Int 66:1\u20139. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00701.x","journal-title":"Kidney Int"},{"key":"4756_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/164_2016_76","volume":"243","author":"P Kolkhof","year":"2017","unstructured":"Kolkhof P, Jaisser F, Kim SY, Filippatos G, Nowack C, Pitt B (2017) Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside. Handb Exp Pharmacol 243:271\u2013305. https:\/\/doi.org\/10.1007\/164_2016_76","journal-title":"Handb Exp Pharmacol"},{"key":"4756_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ki.2011.505","volume":"81","author":"L Shavit","year":"2012","unstructured":"Shavit L, Lifschitz MD, Epstein M (2012) Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Kidney Int 81:955\u2013968. https:\/\/doi.org\/10.1038\/ki.2011.505","journal-title":"Kidney Int"},{"key":"4756_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","volume":"96","author":"BF Palmer","year":"2021","unstructured":"Palmer BF, Carrero JJ, Clegg DJ et al (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744\u2013762. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.014","journal-title":"Mayo Clin Proc"},{"key":"4756_CR30","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402069R","volume":"38","author":"M Webers","year":"2024","unstructured":"Webers M, Yu Y, Eyll J et al (2024) The metalloproteinase ADAM10 sheds angiotensin-converting enzyme (ACE) from the pulmonary endothelium as a soluble, functionally active convertase. FASEB J 38:e70105. https:\/\/doi.org\/10.1096\/fj.202402069R","journal-title":"FASEB J"},{"key":"4756_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-024-00688-8","author":"C Deng","year":"2024","unstructured":"Deng C, Wu Y (2024) Vitamin D-parathyroid hormone-fibroblast growth factor 23 axis and cardiac remodeling. Am J Cardiovasc Drugs. https:\/\/doi.org\/10.1007\/s40256-024-00688-8","journal-title":"Am J Cardiovasc Drugs"},{"key":"4756_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/nep.14281","volume":"29","author":"DYH Yap","year":"2024","unstructured":"Yap DYH, Ma RCW, Wong ECK et al (2024) Consensus statement on the management of hyperkalaemia-an Asia-Pacific perspective. Nephrology (Carlton) 29:311\u2013324. https:\/\/doi.org\/10.1111\/nep.14281","journal-title":"Nephrology (Carlton)"},{"key":"4756_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM et al (2024) Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 20:473\u2013485. https:\/\/doi.org\/10.1038\/s41581-024-00820-6","journal-title":"Nat Rev Nephrol"},{"key":"4756_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","volume":"96","author":"BF Palmer","year":"2021","unstructured":"Palmer BF, Carrero JJ, Clegg DJ et al (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744\u2013762","journal-title":"Mayo Clin Proc"},{"key":"4756_CR35","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12889-025-21851-z","volume":"25","author":"L Deng","year":"2025","unstructured":"Deng L, Guo S, Liu Y, Zhou Y, Liu Y, Zheng X, Yu X, Shuai P (2025) Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health 25:636. https:\/\/doi.org\/10.1186\/s12889-025-21851-z","journal-title":"BMC Public Health"},{"issue":"12","key":"4756_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"2011","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 2011(12):7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl"},{"key":"4756_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1193984","volume":"10","author":"DL Cisneros-Garc\u00eda","year":"2023","unstructured":"Cisneros-Garc\u00eda DL, Sandoval-Pinto E, Cremades R, Ram\u00edrez-de-Arellano A, Garc\u00eda-Guti\u00e9rrez M, Mart\u00ednez-de-Pinillos-Valverde R, Sierra-D\u00edaz E (2023) Non-traditional risk factors of progression of chronic kidney disease in adult population: a scoping review. Front Med 10:1193984. https:\/\/doi.org\/10.3389\/fmed.2023.1193984","journal-title":"Front Med"},{"key":"4756_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3904\/kjim.2021.181","volume":"36","author":"JY Lee","year":"2021","unstructured":"Lee JY, Han SH (2021) Blood pressure control in patients with chronic kidney disease. Korean J Intern Med 36:780\u2013794. https:\/\/doi.org\/10.3904\/kjim.2021.181","journal-title":"Korean J Intern Med"},{"key":"4756_CR39","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1053\/j.jrn.2022.12.003","volume":"33","author":"K Sumida","year":"2023","unstructured":"Sumida K, Biruete A, Kistler BM et al (2023) New insights into dietary approaches to potassium management in chronic kidney disease. J Ren Nutr 33:S6\u2013S12. https:\/\/doi.org\/10.1053\/j.jrn.2022.12.003","journal-title":"J Ren Nutr"},{"key":"4756_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.xkme.2021.03.014","volume":"3","author":"CD Chu","year":"2021","unstructured":"Chu CD, Chen MH, McCulloch CE, Powe NR, Estrella MM, Shlipak MG, Tuot DS (2021) Patient awareness of CKD: a systematic review and meta-analysis of patient-oriented questions and study setting. Kidney Medicine 3:576-585.e571. https:\/\/doi.org\/10.1016\/j.xkme.2021.03.014","journal-title":"Kidney Medicine"},{"key":"4756_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/j.ajkd.2023.05.002","volume":"82","author":"CP Kovesdy","year":"2023","unstructured":"Kovesdy CP (2023) Outcomes associated with potassium abnormalities in CKD: it is time to move to clinical trials. Am J Kidney Dis 82:251\u2013253. https:\/\/doi.org\/10.1053\/j.ajkd.2023.05.002","journal-title":"Am J Kidney Dis"},{"key":"4756_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1053\/j.akdh.2024.08.003","volume":"31","author":"A Rastogi","year":"2024","unstructured":"Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P (2024) Utilization of potassium binders for the management of hyperkalemia in chronic kidney disease: a position statement by US nephrologists. Adv Kidney Dis Health 31:514\u2013522. https:\/\/doi.org\/10.1053\/j.akdh.2024.08.003","journal-title":"Adv Kidney Dis Health"},{"key":"4756_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/hjh.0000000000002216","volume":"38","author":"S Monticone","year":"2020","unstructured":"Monticone S, Sconfienza E, D\u2019Ascenzo F, Buffolo F, Satoh F, Sechi LA, Veglio F, Mulatero P (2020) Renal damage in primary aldosteronism: a systematic review and meta-analysis. J Hypertens 38:3\u201312. https:\/\/doi.org\/10.1097\/hjh.0000000000002216","journal-title":"J Hypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04756-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:30:58Z","timestamp":1772029858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04756-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4756"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04756-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval and patient consent"}}]}}